阿霉素对美国肝细胞癌患者的治疗 - Suppr

Suppr

超能文献

Adriamycin therapy in American patients with hepatocellular carcinoma.

作者信息

Ihde D C, Kane R C, Cohen M H, McIntire K R, Minna J D

出版信息

Cancer Treat Rep. 1977 Oct;61(7):1385-7.

PMID:201380

Abstract

摘要

相似文献

Adriamycin therapy in American patients with hepatocellular carcinoma.阿霉素对美国肝细胞癌患者的治疗

Cancer Treat Rep. 1977 Oct;61(7):1385-7.

Phase II trial of epirubicin in hepatoma.

Cancer Treat Rep. 1986 Aug;70(8):1035-6.

Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.阿霉素与5-氟尿嘧啶治疗晚期肝癌：西南肿瘤协作组的一项研究

Cancer Treat Rep. 1977 Nov;61(8):1595-7.

Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma.聚乙二醇化脂质体阿霉素治疗晚期或不可切除肝细胞癌的初步研究。

Br J Cancer. 2001 Dec 14;85(12):1850-2. doi: 10.1054/bjoc.2001.2149.

[Treatment of hepatocellular carcinoma with adriamycin. Phase II clinical trial].[阿霉素治疗肝细胞癌。II期临床试验]

Gastroenterol Clin Biol. 1984 Aug-Sep;8(8-9):679-80.

Trial of adriamycin in primary hepatocellular carcinoma.阿霉素治疗原发性肝细胞癌的试验。

Ethiop Med J. 1984 Jan;22(1):55-9.

[Should one treat with systemic adriamycin inoperable hepatocellular cancer in cirrhosis?].[对于肝硬化中无法手术切除的肝细胞癌，是否应采用全身性阿霉素进行治疗？]

Gastroenterol Clin Biol. 1982 Mar;6(3):267-71.

Phase II evaluation of doxorubicin plus amiodarone in advanced hepatocarcinoma.阿霉素联合胺碘酮治疗晚期肝癌的II期评估

Gastroenterol Clin Biol. 1991;15(10):774-5.

Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma.肝细胞癌肝移植术后新辅助化疗

Transplant Proc. 1994 Dec;26(6):3568-9.

[Hepatocellular carcinoma with cirrhosis: treatment with doxorubicin. Phase II evaluation].[伴有肝硬化的肝细胞癌：阿霉素治疗。II期评估]

Bull Cancer. 1984;71(5):442-5.

引用本文的文献

Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.用于儿童癌症治疗时，含蒽环类药物的治疗方案与不含蒽环类药物的治疗方案对比。

Cochrane Database Syst Rev. 2014 Sep 4;2014(9):CD006647. doi: 10.1002/14651858.CD006647.pub4.

Molecular targeted therapy in hepatocellular carcinoma: from biology to clinical practice and future.肝细胞癌的分子靶向治疗：从生物学到临床实践及未来

Curr Treat Options Oncol. 2014 Sep;15(3):380-94. doi: 10.1007/s11864-014-0291-7.

A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas.一项多机构 II 期研究评估拉帕替尼在晚期肝细胞癌患者中的疗效和耐受性。

Clin Cancer Res. 2009 Sep 15;15(18):5895-901. doi: 10.1158/1078-0432.CCR-09-0465. Epub 2009 Sep 8.

Current management of advanced hepatocellular carcinoma.晚期肝细胞癌的当前管理

Gastrointest Cancer Res. 2008 Mar;2(2):64-70.

Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma.依托泊苷、阿霉素、顺铂、5-氟尿嘧啶和亚叶酸钙联合化疗用于晚期肝细胞癌患者。

Med Oncol. 2008;25(2):201-6. doi: 10.1007/s12032-007-9013-3. Epub 2007 Oct 6.

Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma.盐酸诺拉曲塞[Thymitaq，AG 337]用于晚期肝细胞癌患者的II期试验。

Invest New Drugs. 2007 Feb;25(1):85-94. doi: 10.1007/s10637-006-9003-x. Epub 2006 Sep 7.

No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinoma.表柔比星与α-2b干扰素联合治疗肝细胞癌无协同活性。

Cancer Chemother Pharmacol. 1995;35(4):334-8. doi: 10.1007/BF00689454.

Right trisegmentectomy for hepatic neoplasms.肝脏肿瘤的右三叶切除术

Surg Gynecol Obstet. 1980 Feb;150(2):208-14.

[Approaches to a selective chemotherapy of hepatocellular carcinoma (author's transl)].肝细胞癌选择性化疗的方法（作者译）

Klin Wochenschr. 1981 Jun 15;59(12):591-8. doi: 10.1007/BF02593848.

Intra-arterial administration of epirubicin in the treatment of nonresectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma.

Cancer Chemother Pharmacol. 1987;19(3):183-9. doi: 10.1007/BF00252970.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验